JPL Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
JPL Wealth Management's PFE Position: Q2 2026 in Review
JPL Wealth Management reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $14.8K and leaving 11,838 shares worth $285K. The position accounts for 0.06% of the portfolio, ranked #114.
JPL Wealth Management first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.14M in Q4 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- JPL Wealth Management held 11,838 shares of Pfizer worth $285K as of Q2 2026.
- JPL Wealth Management sold 567 Pfizer shares in Q2 2026, an estimated $14.8K.
- Pfizer made up 0.06% of JPL Wealth Management's portfolio in Q2 2026, its #114 holding.
- JPL Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
- JPL Wealth Management's Pfizer position peaked at $1.14M in Q4 2023.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.